New e-Health solution developed to prevent cardiovascular disease, dementia from senior citizens
An innovative e-health solution, centered on an interactive online platform, is developed to support seniors in improving their life style to prevent cardiovascular disease, cognitive decline, and dementia. Researchers from the HATICE study presented that the clear answer in a pre-press article published in Journal of Alzheimer's Disease 62(two).
The HATICE trial is now ongoing in Finland, France, and the Netherlands, requiring more than 2,500 people aged 65 years or older, at high risk of cardiovascular illness. Half of the participants have use of an Internet platform where they can follow their cardiovascular risk factors and find information about how best to lessen them by improving their lifestyle. Throughout the platform, they're also able to interact with a technical nurse for additional guidance and service. The other 50% these participants use a simplified platform, with only necessary information along with no interactive features.
The primary objective of this HATICE trial will be to understand whether participants may benefit from using this platform and the interaction with the nurse by reducing their probability of developing cardiovascular disease, cognitive loss, and dementia. For the aim, HATICE is targeted on increasing the awareness of participants on what represents a healthy way of life, while taking into account the specific needs of senior citizens.
Within this study, the researchers compared and integrated the rules for preventing cardiovascular disease available in both three participating countries. The results were used to produce a lifestyle counseling program over the HATICE platform. The recommendations had been uniform, especially about that which defines a healthy lifestyle. This enabled the growth of a stage always applicable in the 3 local settings. However, advice specifically addressed senior citizens was limited.
"The prospect of inventing popular preventative programs in Europe and delivering them through the Internet usually means individuals might have the ability to reach a larger section of the people more simply and cost-effectively. This will enhance our odds of better preventing cardiovascular disease and dementia", says doctor Mariagnese Barbera from the University of Eastern Finland, the lead writer of this analysis.
Professor Miia Kivipelto, a senior researcher of this HATICE trial, '' adds:
"This study illustrates the necessity to increase our knowledge of how to best encourage healthy aging and prevention of cardiovascular disease and dementia in the mature people. The results of this HATICE trial will provide essential details about how to better get a handle on cardiovascular risk factors in this age category, and plan largescale preventative programs."